Positioning the role of urine cytology within the diagnostic pathway for UTUC: supportive but inconclusive.
Cytology
Diagnostics
Upper tract urothelial carcinoma
Urothelial carcinoma
Journal
World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
07
04
2023
accepted:
10
10
2023
medline:
4
12
2023
pubmed:
21
11
2023
entrez:
21
11
2023
Statut:
ppublish
Résumé
With the introduction of kidney-sparing surgery (KSS) for low-risk Upper Tract Urothelial Carcinoma (UTUC), correct risk-stratification has become crucial. High-grade cytology is one of the decisive variables to stratify a tumor as high-risk. To position the role of urine cytology in the diagnostic pathway of UTUC patients, we evaluated the accuracy of urine cytology by comparing the outcomes with histopathology. Patients with UTUC evaluated between 2010 and 2020, and diagnosed by imaging, cytology and histopathology were selected. Descriptive statistics were used to compare cytology with histopathological outcomes using crosstabs. Clinical performance characteristics of cytology were determined for the presence of a malignancy. This study included 176 patients with confirmed histopathological UTUC. Concordance between cytology and biopsy results was found in 14.8% of low-grade tumors and 16.8% of high-grade tumors. Comparing cytology with radical nephroureterectomy (RNU) specimens revealed concordance rates of 1.6% for low-grade tumors and 22.9% for high-grade tumors. Notably, 51.1% of urine cytology results were false negative. Sensitivity for detecting high-grade and low-grade tumors with a positive urine cytology was 56.6% and 52.6%, respectively, with specificities of 54.8% and 37.2%. In the current study, cytology appears to exhibit limited reliability when used as a sole diagnostic tool for assessing tumor grade and consequently risk stratification. It is imperative to recognize these limitations, optimize urine sampling techniques, and leverage a combination of diverse diagnostic methods for the most effective and individualized treatment decision-making.
Identifiants
pubmed: 37987866
doi: 10.1007/s00345-023-04689-1
pii: 10.1007/s00345-023-04689-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3429-3435Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ, Cancer Statistics (2009) Both sexes female both sexes estimated deaths. CA Cancer J Clin 59(4):1–25
Rouprêt, M., et al. EAU Guidelines on Urothelial Carcinomas of the Upper Urinary Tract 2023. Edn. presented at the 38th EAU Annual Congress Milan. European Association of Urology Guidelines Office Arnhem, The Netherlands.
Seisen T, Peyronnet B, Dominguez-Escrig JL, Bruins HM, Yuan CY, Babjuk M et al (2016) Oncologic outcomes of Kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the EAU Non-muscle invasive bladder cancer guidelines panel. Eur Urol 70(6):1052–1068
doi: 10.1016/j.eururo.2016.07.014
pubmed: 27477528
Xu AD, Ng CS, Kamat A, Grossman HB, Dinney C, Sandler CM (2010) Significance of upper urinary tract urothelial thickening and filling defect seen on MDCT urography in patients with a history of urothelial neoplasms. Am J Roentgenol 195(4):959–965
doi: 10.2214/AJR.09.4177
Grahn A, Melle-Hannah M, Malm C, Jäderling F, Radecka E, Beckman M et al (2017) Diagnostic accuracy of computed tomography urography and visual assessment during ureterorenoscopy in upper tract urothelial carcinoma. BJU Int 119(2):289–297
doi: 10.1111/bju.13652
pubmed: 27611622
Cowan NC, Turney BW, Taylor NJ, McCarthy CL, Crew JP (2007) Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour. BJU Int 99(6):1363–1370. https://doi.org/10.1111/j.1464-410X.2007.06766.x
doi: 10.1111/j.1464-410X.2007.06766.x
pubmed: 17428251
Fritz GA, Schoellnast H, Deutschmann HA, Quehenberger F, Tillich M (2006) Multiphasic multidetector-row CT [MDCT] in detection and staging of transitional cell carcinomas of the upper urinary tract. Eur Radiol 16(6):1244–1252
doi: 10.1007/s00330-005-0078-0
pubmed: 16404565
Coleman JA, Clark PE, Bixler BR et al (2023) Diagnosis and management of non-metastatic upper tract urothelial carcinoma: AUA/SUO guideline. J Urol 209(6):1071–1081
doi: 10.1097/JU.0000000000003480
pubmed: 37096584
Gontero, P., et al. Guidelines on Non-muscle-invasive Bladder Cancer [T1, T1 and CIS], in EAU Guidelines, Edn. presented at the 38th EAU Annual Congress Milan. 2023, EAU Guidelines Office, Arnhem, The Netherlands.
Yafi FA, Brimo F, Steinberg J, Aprikian AG, Tanguay S, Kassouf W (2015) Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer. Urol Oncol Semin Orig Investig 33(2):66.e25-66.e31
Têtu B. Diagnosis of urothelial carcinoma from urine. Mod Pathol. 2009;22[October 2008]:S53–9.
Messer J, Shariat SF, Brien JC, Herman MP, Ng CK, Scherr DS et al (2011) Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU Int 108(5):701–705
doi: 10.1111/j.1464-410X.2010.09899.x
pubmed: 21320275
Lodde M, Mian C, Wiener H, Haitel A, Pycha A, Marberger M (2001) Detection of upper urinary tract transitional cell carcinoma with ImmunoCyt: A preliminary report. Urology 58(3):362–366
doi: 10.1016/S0090-4295(01)01182-7
pubmed: 11549481
Dev HS, Poo S, Armitage J, Wiseman O, Shah N, Al-Hayek S (2017) Investigating upper urinary tract urothelial carcinomas: a single-centre 10-year experience. World J Urol 35(1):131–138. https://doi.org/10.1007/s00345-016-1820-8 . (Epub 2016 Apr 29 PMID: 27129575)
doi: 10.1007/s00345-016-1820-8
pubmed: 27129575
Epstein JI, Eble JN, Sauter G, Sesterhenn IA, (2004). World Health Organization Classification of tumors: pathology and genetics of tumours of the urinary system and male genital organs World Health Organization Classification of tumors: pathology and genetics of tumours of the urinary system and male genital organs.
Baard J, Shariat SF, Roupret M et al (2022) Adherence to guideline recommendations in the management of upper tract urothelial carcinoma: an analysis of the CROES–UTUC registry. World J Urol 40:2755–2763. https://doi.org/10.1007/s00345-022-04168-z
doi: 10.1007/s00345-022-04168-z
pubmed: 36197507
Potretzke AM, Knight BA, Vetter JM, Anderson BG, Hardi AC, Bhayani SB, Figenshau RS (2016) Diagnostic utility of selective upper tract urinary cytology: a systematic review and meta-analysis of the literature. Urology 96:35–43. https://doi.org/10.1016/j.urology.2016.04.030 . (Epub 2016 May 2)
doi: 10.1016/j.urology.2016.04.030
pubmed: 27151340
Freund JE, Duivenvoorden MJC., Sikma BT, Vernooij RWM, Savci-Heijink CD, Legemate JD, de Reijke TM (2020) The Diagnostic yield and concordance of ureterorenoscopic biopsies for grading of upper tract urothelial carcinoma: a dutch nationwide analysis. J Endourology. https://doi.org/10.1089/end.2020.0246
doi: 10.1089/end.2020.0246
Zhang ML, Rosenthal DL, VandenBussche CJ (2017) Upper urinary tract washings outperform voided urine specimens to detect upper tract high-grade urothelial carcinoma. Diagn Cytopathol 45(8):700–704
doi: 10.1002/dc.23746
pubmed: 28556525
Bibbo M, Gill WB, Harris MJ, Thomsen SWG (1974) Retrograde brushing as a diagnostic procedure of ureteral, renal pelvic and renal calyceal lesions. a preliminary report. Acta Cytol 18(2):137–41
pubmed: 4133107
Malm C, Grahn A, Jaremko G, Tribukait B, Brehmer M (2017) Diagnostic accuracy of upper tract urothelial carcinoma: how samples are collected matters. Scand J Urol 51(2):137–145
doi: 10.1080/21681805.2017.1295102
pubmed: 28385123
Hentschel AE, van der Toom EE, Vis AN, Ket JCF, Bosschieter J, Heymans MW, van Moorselaar RJA, Steenbergen RDM, Nieuwenhuijzen JA (2021) A systematic review on mutation markers for bladder cancer diagnosis in urine. BJU Int 127(1):12–27. https://doi.org/10.1111/bju.15137 . (Epub 2020 Aug 16)
doi: 10.1111/bju.15137
pubmed: 32539176
Territo A, Gallioli A, Diana P, Boissier R, Fontana M, Gaya JM, Sanguedolce F, Calderón J, Piana A, Fontanet S, Algaba F, Palou J, Breda A (2022) DNA Methylation urine biomarkers test in the diagnosis of upper tract urothelial carcinoma: results from a single-center prospective clinical trial. J Urol 208(3):570–579. https://doi.org/10.1097/JU.0000000000002748 . (Epub 2022 May 12)
doi: 10.1097/JU.0000000000002748
pubmed: 35549312
Ghoreifi A, Seyedian SL, Piatti P, Chew YC, Jara B, Sanossian L, Bhasin JM, Yamada T, Fuchs G, Bhanvadia S, Sotelo R, Hung A, Aron M, Desai M, Gill I, Daneshmand S, Liang G, Djaladat H. (1974)A Urine-based DNA Methylation Marker Test to Detect Upper Tract Urothelial Carcinoma: A Prospective Cohort Study. J Urol
Skolarikos A, Griffiths TR, Powell PH, Thomas DJ, Neal DE, Kelly JD (2003) Cytologic analysis of ureteral washings is informative in patients with grade 2 upper tract TCC considering endoscopic treatment. Urology 61(6):1146–1150. https://doi.org/10.1016/s0090-4295[03]00026-8
doi: 10.1016/s0090-4295[03]00026-8
pubmed: 12809884
Renshaw AA (2006) Comparison of ureteral washing and biopsy specimens in the community setting. Cancer 108(1):45–48. https://doi.org/10.1002/cncr.21456 . (PMID: 16302250)
doi: 10.1002/cncr.21456
pubmed: 16302250
Zhao Y, Deng FM, Melamed J, Huang WC, Huang H, Ren Q (2021) Diagnostic role of urine cytology and ureteroscopic biopsies in detection of high grade upper tract urothelial carcinoma. Am J Clin Exp Urol 9(3):221–228
pubmed: 34327261
pmcid: 8303026